AMEX · Biotechnology

TOVX (TOVX) Stock

$0.22 +6.05% AMEX: TOVX Healthcare

Valuation

MetricValue
Price$0.22
Market Cap$10.22M
P/E Ratio-0.14
P/B Ratio0.71
P/S Ratio35.69
EPS (TTM)$-2.08
52-Week High$0.86
52-Week Low$0.16
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-166.67%
ROA-65.79%
ROCE-100.00%
Gross Margin92.00%
Operating Margin-72.45%
Net Margin-71.53%
Debt/Equity0.13
Current Ratio1.70

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$-14.0M$-22.0M$-21.0M$-26.0M$-15.0M
Net Profit$-14.0M$-20.0M$-18.0M$-26.0M$-25.0M
EPS$-1.90$-32.66$-28.48$-19.03$-2.08
Op Margin—————

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$70.0M$72.0M$55.0M$35.0M$38.0M
Total Liabilities$5.0M$17.0M$16.0M$16.0M$23.0M
Cash$67.0M$42.0M$23.0M$12.0M$13.0M
Borrowings$2.0M$2.0M$2.0M$2.0M$3.0M

Latest News

Theriva Biologics Gets Spain Approval for Phase 2a Trial of Pancreatic Cancer Therapy MT Newswires · Jul 7, 2026 Theriva™ Biologics Announces Regulatory Authorization to Proceed with a VIRAGE2 Phase 2a Clinical Trial to Evaluate More Frequent Dosing of VCN-01 (zabilugene almadenorepvec) in First-Line Patients with Metastatic Pancreatic Ductal Adenocarcinoma GlobeNewswire · Jul 7, 2026 Theriva™ Biologics Announces Results from VCN-01 Phase 1 Clinical Trial in Head and Neck Cancer Published in Clinical Cancer Research GlobeNewswire · Jun 11, 2026 Theriva Biologics: Q1 Earnings Snapshot Associated Press · May 5, 2026 Theriva™ Biologics Reports First Quarter 2026 Operational Highlights and Financial Results GlobeNewswire · May 5, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-13.0M$-19.0M$-19.0M$-17.0M$-17.0M
Investing Cash Flow$0$-5.0M$0$0$0
Financing Cash Flow$8.0M$-3.0M$-2.0M$0$3.0M
Net Cash Flow$61.0M$-25.0M$-19.0M$-12.0M$1.0M
Free Cash Flow$-13.0M$-19.0M$-19.0M$-17.0M$-17.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-134.54%
Quick Ratio1.63
Interest Coverage—
Return 1Y-48.32%
Return 3Y-98.61%
Return 5Y-99.81%

Ownership

Insiders Held1.63%
Institutions Held4.32%
Institutions Float Held4.39%
Institutional HolderSharesReport Date
Geode Capital Management, LLC450,2632026-03-31
Virtu Financial LLC253,2182026-03-31
Vanguard Fiduciary Trust Co241,7802026-03-31
UBS Group AG225,6242026-03-31
Vanguard Capital Management LLC192,4042026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
BCTXZBriaCell Therapeutics Corp. Warrant $0.10 +8.47% -0.30 $188186 0.00%
BIVI $1.52 +6.29% -0.11 $11.46M 0.00%
CARMCarisma Therapeutics, Inc. $0.01 -5.17% 0.01 $230148 0.00%
CMMBChemomab Therapeutics Ltd. $1.43 -2.72% -1.30 $8.80M 0.00%
ELAB $0.92 +2.21% 0.00 $1.78M 0.00%

About TOVX

TOVX is led by CEO Steven A. Shallcross, employs 20 people, headquartered in US, publicly traded since 2006.

TOVX stock trades at $0.22 with a market capitalization of $10.22M. The stock is valued at a price-to-earnings (P/E) ratio of -0.14, price-to-book of 0.71, price-to-sales of 35.69. Over the past 52 weeks the stock has ranged between $0.16 and $0.86, and currently trades 74.4% below its 52-week high.

On profitability, TOVX generates a return on equity (ROE) of -166.67%, return on capital employed of -100.00%, an operating margin of -72.45%, a net profit margin of -71.53%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides